2026 NPPES data Specialist NPI 1558338939 MD
Verify on CMS →

ROY MISIRLIYAN, MD

Specialist in YPSILANTI, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 577 beneficiaries · Specialist avg: 1K
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$34.21
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ROY MISIRLIYAN, MD filed 2,932 Medicare Part D claims in 2023 as a Specialist in YPSILANTI, Michigan, prescribing 80% generic.

3K
Part D claims, 2023
80%
generic prescribing
$34.21
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROY MISIRLIYAN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,932 Top 12% higher than 88% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ROY MISIRLIYAN, MD?

Quality data not reported

NPI registry status

Active

Issued 03/03/2006

NPI 1558338939

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

2,932 99% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

Specialty distribution in Michigan

How Specialist compares to other specialties among Michigan providers

Michigan providers

Specialist share within Michigan

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Michigan

Specialty board-certification context

Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Specialist ABMS/AOA estimate

Est. board-certified rate (Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROY MISIRLIYAN, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 5325 ELLIOTT DR, YPSILANTI, MI, 48197, with a listed phone of (734) 712-8000. NPI 1558338939 was issued on 03/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MISIRLIYAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,932 prescription claims written by this provider, covering 577 Medicare beneficiaries and totaling roughly $756K in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5325 ELLIOTT DR
YPSILANTI, MI 48197

Provider Details

NPI 1558338939
Specialty Specialist
Credentials MD
Gender Male
NPI Issued 03/03/2006

Hospital and facility affiliations

Facilities where ROY MISIRLIYAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

IHA HEALTH SERVICES CORPORATION
CHELSEA, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROY MISIRLIYAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$34

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to ROY MISIRLIYAN, MD. To verify ROY MISIRLIYAN, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ROY MISIRLIYAN, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 2,932 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,932
Total Claims
$756K
Total Drug Cost
577
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,671
Total Day Supply
228,979
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$698K
Generic Drug Cost
$58K

Patient Demographics

Average Patient Age
78.0 years
Avg HCC Risk Score
1.41
Gender Split
48% female / 52% male
Age Distribution
<65: 17, 65-74: 185, 75-84: 236, 85+: 139

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROY MISIRLIYAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Metoprolol Succinate
352
Eliquis
Apixaban
335
Rosuvastatin Calcium
285
Atorvastatin Calcium
218
Amlodipine Besylate
162
Lisinopril
150
Carvedilol
123
Xarelto
Rivaroxaban
122
Metoprolol Tartrate
100
Furosemide
91

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How ROY MISIRLIYAN, MD fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

ROY MISIRLIYAN, MD's 2,932 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as MISIRLIYAN.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROY MISIRLIYAN, MD's specialty?
ROY MISIRLIYAN, MD specializes in Specialist and practices in YPSILANTI, Michigan. Credentials: MD.
How much does ROY MISIRLIYAN, MD prescribe under Medicare Part D?
In 2023, ROY MISIRLIYAN, MD wrote 2,932 Medicare Part D claims totaling $756K in drug costs for 577 beneficiaries.
Where is ROY MISIRLIYAN, MD located?
ROY MISIRLIYAN, MD is located at 5325 ELLIOTT DR, YPSILANTI, MI, 48197. Phone: (734) 712-8000.
What is ROY MISIRLIYAN, MD's NPI number?
ROY MISIRLIYAN, MD's National Provider Identifier (NPI) is 1558338939, issued on 03/03/2006.
Does ROY MISIRLIYAN, MD prescribe more brand-name or generic drugs?
ROY MISIRLIYAN, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $698K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does ROY MISIRLIYAN, MD prescribe most often?
Based on 2023 Medicare Part D data, ROY MISIRLIYAN, MD's most frequently prescribed drugs include Metoprolol Succinate, Eliquis, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROY MISIRLIYAN, MD accept Medicare?
ROY MISIRLIYAN, MD appears in CMS Medicare data with 2,932 Part D claims and 577 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROY MISIRLIYAN, MD's credentials?
ROY MISIRLIYAN, MD's NPI is 1558338939 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology